Who Owns Ascendis Pharma A/S Stock?
NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 101.00%
- Institutions (% of float)
- 101.92%
- Held by insiders
- 0.90%
- Institutional holders
- 487
- Institutions 99.1%
- Insiders 0.9%
- Public and other 0.0%
Who owns Ascendis Pharma A/S stock?
Institutional investors own about 101.0% of Ascendis Pharma A/S's shares, spread across 487 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.90% of ASND.
The largest institutional holders are RA Capital Management, L.P. (0.00%), T. Rowe Price Investment Management, Inc. (0.00%) and Westfield Capital Management Co LP (0.00%). Together, the top 10 institutions control 0.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ASND positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ASND
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 10.28M | 0.00% | 0.0% |
| T. Rowe Price Investment Management, Inc. | 6.75M | 0.00% | +9.6% |
| Westfield Capital Management Co LP | 5.13M | 0.00% | +6.8% |
| Avoro Capital Advisors LLC | 5.11M | 0.00% | +1.0% |
| Jupiter Topco LLC | 3.65M | 0.00% | +100.0% |
| FMR, LLC | 3.45M | 0.00% | -2.8% |
| Artisan Partners Limited Partnership | 2.63M | 0.00% | -18.5% |
| Blackrock Inc. | 2.21M | 0.00% | +234.6% |
| Massachusetts Financial Services Co. | 1.90M | 0.00% | +1.1% |
| Wellington Management Group, LLP | 1.55M | 0.00% | -11.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ASND
| Fund | Shares | % Held |
|---|---|---|
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 3.36M | 0.00% |
| MFS Series Trust IV-MFS Mid Cap Growth Fund | 1.27M | 0.00% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.10M | 0.00% |
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | 1.00M | 0.00% |
| Growth Fund of America | 894.76K | 0.00% |
| JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund | 795.73K | 0.00% |
| American Century Mutual Funds, Inc.-ULTRA FUND | 664.00K | 0.00% |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 639.11K | 0.00% |
| SmallCap World Fund Inc | 570.65K | 0.00% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 500.00K | 0.00% |
Frequently asked questions
Who is the largest shareholder of Ascendis Pharma A/S?
RA Capital Management, L.P. is the largest institutional shareholder of ASND, owning 0.00% of shares outstanding (10.28M shares) as of its latest 13F filing.
What percentage of Ascendis Pharma A/S is owned by institutions?
Institutions own about 101.0% of ASND shares and 101.9% of the public float.
How much of Ascendis Pharma A/S do insiders own?
Insiders, such as officers and directors, own about 0.90% of ASND shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.